Back to search

Peptide record

TPDB15356

N29N Antibacterial Anticancer Antifungal standard
30 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB15356
N29N
Antibacterial Anticancer Antifungal
Anti-infective peptides Cancer-related peptides
dbAMP Peptipedia AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF
standard
No
A 30-aa standard natural multi-activity (Antibacterial, Anticancer, and Antifungal) peptide sequence curated from dbAMP, Peptipedia, AntiCP 2.0, and other sources, with an available 3D structural model.
Sequence
PDEDAINNALNKVCSTGRRQRSICKQLLKK
Physicochemical Analysis
C141H248N48O45S2
HMFWY
K
3399.93
10.16
7
3
8
+4
11.10
-0.940
81.33
Mammalian: >20 hour Yeast: >20 hour E.coli: ?
125
3.68
10
Residue Composition
number
2
A
3
R
3
N
2
D
2
C
1
E
2
Q
1
G
0
H
2
I
3
L
4
K
0
M
0
F
1
P
2
S
1
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 2 R: 3 N: 3 D: 2 C: 2 E: 1 Q: 2 G: 1 H: 0 I: 2 L: 3 K: 4 M: 0 F: 0 P: 1 S: 2 T: 1 W: 0 Y: 0 V: 1
Chemical Descriptors
30
C141H248N48O45S2
3399.93
10.16
+4
11.10
-0.940
Free
L
Linear
Free
Antibacterial and Anticancer
Synthetic peptide
Evidence Records 12 records
Evidence 1 Activity

Activity

100% cell viability at 5 µM
Anticancer

Target

Colon Cancer
SW-480
Colon

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2012

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

40% cell viability at 50 µM
Anticancer

Target

Colon Cancer
SW-480
Colon

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2012
Evidence 3 Activity

Activity

100% cell viability at 5 µM
Anticancer

Target

Lymphoma Cancer
U-937
Blood

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2012
Evidence 4 Activity

Activity

<40% cell viability at 50 µM
Anticancer

Target

Lymphoma Cancer
U-937
Blood

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2012
Evidence 5 Activity

Activity

<100% cell viability at 5 µM
Anticancer

Target

Gastric Cancer
SNU-1
Stomach

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2012
Evidence 6 Activity

Activity

<20% cell viability at 50 µM
Anticancer

Target

Gastric Cancer
SNU-1
Stomach

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2012
Evidence 7 Activity

Activity

100% cell viability at 5 µM
Anticancer

Target

Colon Cancer
SW-480
Colon

Assay & Model

Cell Viability assay

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2012
Evidence 8 Activity

Activity

40% cell viability at 50 µM
Anticancer

Target

Colon Cancer
SW-480
Colon

Assay & Model

Cell Viability assay

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2012
Evidence 9 Activity

Activity

100% cell viability at 5 µM
Anticancer

Target

Lymphoma Cancer
U-937
Blood

Assay & Model

Cell Viability assay

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2012
Evidence 10 Activity

Activity

<40% cell viability at 50 µM
Anticancer

Target

Lymphoma Cancer
U-937
Blood

Assay & Model

Cell Viability assay

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2012
Evidence 11 Activity

Activity

<100% cell viability at 5 µM
Anticancer

Target

Gastric Cancer
SNU-1
Stomach

Assay & Model

Cell Viability assay

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2012
Evidence 12 Activity

Activity

<20% cell viability at 50 µM
Anticancer

Target

Gastric Cancer
SNU-1
Stomach

Assay & Model

Cell Viability assay

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2012